British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...

The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...

The number of significant shareholder protests has more than doubled so far this year compared with a year ago, with 11 FTSE ...

Irritable Bowel Syndrome Treatment Market PORTLAND, OR, UNITED STATES, August 11, 2025 /EINPresswire / -- The global irritable bowel syndrome ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

GlaxoSmithKline Pharmaceuticals' shares fell by 2% in Thursday's morning trade, reflecting a bearish market sentiment. The company is currently trading at Rs 2,680.10 per share.

Urgent need for standardization in dental education and clinical practices: Dr Ashok Dhoble: Shardul Nautiyal, Mumbai Monday, August 11, 2025, 08:00 Hrs [IST] Dr Ashok Dhoble, sec ...

Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...

The Food & Beverage sector maintained its leadership position with a 22% share of total ad volumes, followed by the personal ...

Melrose CEO Peter Dilnot has overtaken AstraZeneca’s Pascal Soriot as the UK’s highest-paid FTSE 100 boss after a £45m payout, fuelling fresh debate over executive pay gaps.

Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.

In a report released today, Justin Smith from Bernstein maintained a Buy rating on GlaxoSmithKline, with a price target of £21.70. The company’s shares closed today at p1,373.00. Take advantage of ...